Abstract 9517: Under-Utilization of Conventional Guideline-Directed Medical Therapy Among Patients Eligible for the Recent Large-Scale Clinical Trials of Heart Failure With Reduced Ejection Fraction

Satoshi Shoji,Shun Kohsaka,Yasuyuki Shiraishi,Mitsuaki Sawano,Nobuhiro Ikemura,Nozomi Niimi,Takashi Kohno,Ayumi Goda,Yuji Nagatomo,Mike Saji,Makoto Takei,Shintaro Nakano,Keiichi Fukuda,Tsutomu Yoshikawa

Abstract 9517: Under-Utilization of Conventional Guideline-Directed Medical Therapy Among Patients Eligible for the Recent Large-Scale Clinical Trials of Heart Failure With Reduced Ejection Fraction

2021

Satoshi Shoji
Shun Kohsaka
Yasuyuki Shiraishi
Mitsuaki Sawano
Nobuhiro Ikemura
Nozomi Niimi
Takashi Kohno
Ayumi Goda
Yuji Nagatomo
Mike Saji
Makoto Takei
Shintaro Nakano
Keiichi Fukuda
Tsutomu Yoshikawa

Introduction: Recent large-scale clinical trials of novel heart failure (HF) agents (angiotensin receptor-neprilysin inhibitor, sodium-glucose cotransporter 2 inhibitor, and ivabradine) emphasize t...

Keywords:

Ivabradine
Renin–angiotensin system
Ejection fraction
Guideline
Heart failure
Medicine
Cardiology
Internal medicine
Clinical trial
medical therapy

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations